Clinical Trial

Study of AV-1959D, an Amyloid Beta Vaccine

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Phase 1 clinical trial of AV-1959 amyloid-β vaccine for Alzheimer's disease (AD).
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2022-11-30; most recent amendment 2026-03-23.
Status change: Recruiting → Active, Not Recruiting 2025-04-09
Status change: Not Yet Recruiting → Recruiting 2023-02-07
Trial Details
NCT Number NCT05642429
Lead Sponsor Institute for Molecular Medicine
Collaborators: National Institute on Aging (NIA), Clinartis
Conditions Alzheimer Disease
Enrollment 48 participants
Start Date 2023-02-27
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-11-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-27